Van der Linden, Lorenz http://orcid.org/0000-0001-5195-1891
Hias, Julie
Walgraeve, Karolien
Tournoy, Jos
Van Aelst, Lucas
Vandenbriele, Christophe
Article History
Accepted: 2 November 2022
First Online: 21 November 2022
Declarations
:
: JH, LVDL, and CVDB are grant recipients of the Clinical Research Fund of UZ Leuven, Leuven, Belgium.
: LVA received lecture fees from Novartis. The other authors declare that they have nothing to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: LVDL provided the idea and wrote the first draft. Figures were rendered by JH. All authors reviewed the manuscript, provided substantial contributions, and approved its submission.